PNC Financial Services Group
SGMO

PNC Financial Services Group’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

PNC Financial Services Group’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$37K Hold
150,000
– – ﹤0.01% 3389
2025
Q4 		$63K Buy
150,000
+115,000
+329% +$61K ﹤0.01% 3080
2025
Q3 		$23.6K Hold
35,000
– – ﹤0.01% 3562
2025
Q2 		$18.9K Sell
35,000
-623
-2% -$370 ﹤0.01% 3599
2025
Q1 		$23.4K Buy
35,623
+9,545
+37% +$10.1K ﹤0.01% 3472
2024
Q4 		$26.6K Buy
26,078
+25,000
+2,319% +$45.7K ﹤0.01% 3399
2024
Q3 		$934 Hold
1,078
– – ﹤0.01% 4458
2024
Q2 		$386 Sell
1,078
-124
-10% -$67 ﹤0.01% 4566
2024
Q1 		$805 Hold
1,202
– – ﹤0.01% 4416
2023
Q4 		$653 Buy
1,202
+623
+108% +$287 ﹤0.01% 4369
2023
Q3 		$347 Hold
579
– – ﹤0.01% 4495
2023
Q2 		$753 Sell
579
-428
-43% -$585 ﹤0.01% 4542
2023
Q1 		$1.77K Sell
1,007
-301
-23% -$859 ﹤0.01% 4339
2022
Q4 		$4.11K Sell
1,308
-2,571
-66% -$9.98K ﹤0.01% 4058
2022
Q3 		$19K Buy
3,879
+744
+24% +$3.82K ﹤0.01% 3479
2022
Q2 		$13K Sell
3,135
-828
-21% -$3.58K ﹤0.01% 3693
2022
Q1 		$23K Buy
3,963
+3,508
+771% +$20.9K ﹤0.01% 3503
2021
Q4 		$3K Hold
455
– – ﹤0.01% 4090
2021
Q3 		$4K Hold
455
– – ﹤0.01% 4002
2021
Q2 		$5K Hold
455
– – ﹤0.01% 3894
2021
Q1 		$6K Hold
455
– – ﹤0.01% 3783
2020
Q4 		$7K Hold
455
– – ﹤0.01% 3655
2020
Q3 		$4K Hold
455
– – ﹤0.01% 3722
2020
Q2 		$4K Sell
455
-1,500
-77% -$13.9K ﹤0.01% 3684
2020
Q1 		$12K Buy
1,955
+1,500
+330% +$11.1K ﹤0.01% 3350
2019
Q4 		$4K Hold
455
– – ﹤0.01% 3698
2019
Q3 		$4K Hold
455
– – ﹤0.01% 3776
2019
Q2 		$5K Hold
455
– – ﹤0.01% 3747
2019
Q1 		$4K Hold
455
– – ﹤0.01% 3790
2018
Q4 		$5K Hold
455
– – ﹤0.01% 3721
2018
Q3 		$8K Hold
455
– – ﹤0.01% 3734
2018
Q2 		$6K Hold
455
– – ﹤0.01% 3808
2018
Q1 		$9K Buy
+455
New +$9.73K ﹤0.01% 3762
2016
Q3 		– Sell
-432
Closed -$3K – 4242
2016
Q2 		$3K Sell
432
-17
-4% -$108 ﹤0.01% 4057
2016
Q1 		$3K Buy
449
+16
+4% +$96 ﹤0.01% 4073
2015
Q4 		$4K Hold
433
– – ﹤0.01% 3958
2015
Q3 		$2K Sell
433
-14,167
-97% -$117K ﹤0.01% 4306
2015
Q2 		$162K Buy
14,600
+272
+2% +$3.51K ﹤0.01% 2365
2015
Q1 		$226K Sell
14,328
-12,900
-47% -$200K ﹤0.01% 2147
2014
Q4 		$413K Hold
27,228
– – ﹤0.01% 1654
2014
Q3 		$294K Buy
27,228
+27,000
+11,842% +$353K ﹤0.01% 1771
2014
Q2 		$3K Buy
228
+30
+15% +$432 ﹤0.01% 3447
2014
Q1 		$4K Sell
198
-40,302
-100% -$777K ﹤0.01% 3318
2013
Q4 		$562K Hold
40,500
– – ﹤0.01% 1307
2013
Q3 		$424K Buy
+40,500
New +$402K ﹤0.01% 1445

Other funds holding SGMO

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

PNC Financial Services Group's SGMO Position: Q1 2026 in Review

PNC Financial Services Group held its SANGAMO THERAPEUTICS INC (SGMO) position steady in Q1 2026 at 150,000 shares worth $37K. The position accounts for ﹤0.01% of the portfolio, ranked #3389.

PNC Financial Services Group first reported a position in SGMO in Q3 2013 and has held it in 45 quarters since. The position peaked at $562K in Q4 2013. 112 funds tracked by Wall St. Rank hold SGMO as of Q1 2026.

  • PNC Financial Services Group held 150,000 shares of SANGAMO THERAPEUTICS INC worth $37K as of Q1 2026.
  • PNC Financial Services Group left its SANGAMO THERAPEUTICS INC share count unchanged in Q1 2026.
  • SANGAMO THERAPEUTICS INC made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #3389 holding.
  • PNC Financial Services Group first reported a position in SANGAMO THERAPEUTICS INC in Q3 2013 and has held it in 45 quarters since.
  • PNC Financial Services Group's SANGAMO THERAPEUTICS INC position peaked at $562K in Q4 2013.
  • 112 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.